Hayes Micaela, Gregory Patrick, Smith Benjamin, Champagne Brittney, Patel Amit, Alvarado Holly, Roberson Cindy, Yang Chengxin, Lee Hui-Jie, Erkanli Alaattin
J Am Pharm Assoc (2003). 2024 Jul-Aug;64(4S):102127. doi: 10.1016/j.japh.2024.102127. Epub 2024 May 23.
The Statin Use in Persons with Diabetes (SUPD) measure is a Star measure by the Center for Medicare & Medicaid Services. The Duke Population Health Management Office has a team of pharmacists and pharmacy students who conduct targeted outreach to patients at risk of failing statin quality measures. Pharmacy services are embedded in select primary care clinics and other clinics are supported remotely.
The primary objective of this review is to compare the initiation rates of recommended statin prescriptions between embedded pharmacist versus remote pharmacist versus remote student pharmacist outreach groups, all of which have different levels of autonomy within pharmacy practice. The secondary objectives are to identify the barriers to the implementation of statin therapy and to assess the statin drugs and intensity of the statins prescribed.
A single-center, retrospective chart review was performed for SUPD patients with Medicare insurance. SUPD patients included patients between 40 and 75 years of age, diagnosed with type 2 diabetes, and were not dispensed at least 1 statin medication of any intensity during the 6-month measurement period. The primary outcome was the initiation of recommended statin medications prescribed, or pended for the primary care provider to prescribe, for qualifying patients by embedded, remote, and remote student pharmacists. Secondary outcomes included the reasons for the nonimplementation of statin recommendations, reasons statin therapy was not prescribed to patients contributing to the SUPD measure gap, and statin drug and dose prescribed for appropriateness.
A total of 189 patients were included in the evaluation. In this study, 34.9% of the patients filled the prescribed or pended statin prescription and 83.3% of patients filled the prescribed or pended statin prescription at the recommended intensity according to the American College of Cardiology/American Hospital Association guidelines, effectively closing the SUPD measure gap. The initiation rates of recommended statin prescriptions between the embedded pharmacist, remote pharmacist, and remote student pharmacist outreach were numerically different at 36.7%, 28.2%, and 36.7%, respectively, even though not statistically different (P = 0.61).
Remote student pharmacists' performance was equal to that of the embedded pharmacists when comparing the initiation rates of statin medications prescribed or pending the primary care provider's approval. The most common reason for nonimplementation of statin therapy is that the statin was refused by the patient. Atorvastatin and rosuvastatin were the two most commonly prescribed statins.
糖尿病患者他汀类药物使用(SUPD)指标是医疗保险和医疗补助服务中心的一项星级指标。杜克大学人口健康管理办公室有一组药剂师和药学专业学生,他们对有他汀类药物质量指标不达标的风险患者进行有针对性的宣传。药学服务嵌入到部分基层医疗诊所,其他诊所则通过远程方式提供支持。
本综述的主要目的是比较嵌入式药剂师、远程药剂师和远程药学专业学生宣传组之间推荐他汀类药物处方的起始率,这三组在药学实践中的自主程度不同。次要目的是确定他汀类药物治疗实施的障碍,并评估所开具的他汀类药物及其强度。
对参加医疗保险的SUPD患者进行单中心回顾性病历审查。SUPD患者包括年龄在40至75岁之间、诊断为2型糖尿病且在6个月的测量期内未接受任何强度的至少1种他汀类药物治疗的患者。主要结局是嵌入式、远程和远程药学专业学生药剂师为符合条件的患者开具或待基层医疗服务提供者开具的推荐他汀类药物的起始情况。次要结局包括他汀类药物推荐未实施的原因、未向导致SUPD指标差距的患者开具他汀类药物治疗的原因,以及所开具他汀类药物及其剂量的适宜性。
共有189名患者纳入评估。在本研究中,34.9%的患者填写了开具或待开具的他汀类药物处方,83.3%的患者按照美国心脏病学会/美国医院协会指南以推荐强度填写了开具或待开具的他汀类药物处方,有效缩小了SUPD指标差距。嵌入式药剂师、远程药剂师和远程药学专业学生宣传组之间推荐他汀类药物处方的起始率在数值上有所不同,分别为36.7%、28.2%和36.7%,尽管差异无统计学意义(P = 0.61)。
在比较开具或待基层医疗服务提供者批准的他汀类药物起始率时,远程药学专业学生的表现与嵌入式药剂师相当。他汀类药物治疗未实施的最常见原因是患者拒绝使用他汀类药物。阿托伐他汀和瑞舒伐他汀是最常开具的两种他汀类药物。